Get started
Author

Jun Morita

ORCID: 0000-0002-8242-0812
Observed ORCID: 0000-0002-8242-0812
OpenAlex ID: A5013666446
Phase I studies assessing safety and pharmacokinetics of nacubactam administered alone or in combination with cefepime or aztreonam in Japanese healthy participants
2026 · Jun Morita, Noriko Hida, et al. · Antimicrobial Agents and Chemotherapy · 3
Pharmacokinetic Bioequivalence, Safety, and Immunogenicity of DMB-3115, an Ustekinumab Biosimilar, and EU- and US-Stelara in Healthy Adult Participants: A Randomized, Double-Blind, Single-Dose Study
2025 · Jun Morita, Rainard Fuhr, et al. · Advances in Therapy · 3
PDF
Evaluation of drug-drug interaction between nacubactam and β-lactam antibiotic (cefepime, aztreonam, meropenem, or piperacillin) in Japanese healthy participants
2026 · Jun Morita, Hiroki Sato, et al. · Antimicrobial Agents and Chemotherapy · 2
A multi-center, open-label, two-part study to investigate the effect of renal function and hemodialysis on the pharmacokinetics of the novel β-lactamase inhibitor nacubactam
2026 · Jun Morita, Kazuya Ishiwata, et al. · Antimicrobial Agents and Chemotherapy · 2
Pharmacokinetic analysis of nacubactam, a novel β-lactamase inhibitor, co-administered with meropenem in patients with a complicated urinary tract infection
2026 · Jun Morita, Kazuya Ishiwata, et al. · JAC-Antimicrobial Resistance · 2
Association Between Efficacy and Pharmacokinetics of DMB-3115 and its Originator Ustekinumab in Patients with Chronic Plaque Psoriasis: An Exposure–Response Analysis
2026 · Hironori Konishi, Takeyuki Shindo, et al. · Advances in Therapy · 1
PDF
Evidence of intrapulmonary penetration of nacubactam, a novel β-lactamase inhibitor, following coadministration of nacubactam with meropenem in healthy adults
2026 · Jun Morita, Kazuya Ishiwata, et al. · Antimicrobial Agents and Chemotherapy · 1
PDF
Novel Frostbite Cooling Device for Real-time Assessment and Prevention of Chemotherapy-induced Peripheral Neuropathy
2025 · Yuki Matsui, Hirotaka Kishi, et al. · Plastic & Reconstructive Surgery Global Open · 1
Correction: Pharmacokinetics, Safety, and Immunogenicity of DMB-3115, a Ustekinumab Biosimilar for Immune-Mediated Diseases, in Healthy Japanese Male Participants: A Randomized, Double-Blind, Single-Dose Study
2026 · Hironori Konishi, Yuji Kumagai, et al. · Advances in Therapy
PDF
Pharmacokinetics, Safety, and Immunogenicity of DMB-3115, a Ustekinumab Biosimilar for Immune-Mediated Diseases, in Healthy Japanese Male Participants: A Randomized, Double-Blind, Single-Dose Study
2026 · Hironori Konishi, Yuji Kumagai, et al. · Advances in Therapy
PDF
Efficacy of perioperative oral cefcapene pivoxil for surgical site infection prophylaxis in patients with urological diseases
2022 · Michiko Tanaka, Hideki Sugita, et al. · The Showa University Journal of Medical Sciences
PDF
Works count: 11
Citation count: 15
H-index: 2
I10-index:
Year
Topic
Type